Search Results
Slidesets
Principles and reality of HIV drug resistance in sub-Saharan Africa - Bruce Richman
Presented at:
INTEREST 2015
Slidesets
Rationale for starting therapy early - Charles Boucher, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2014
Slidesets
Immunological Profiles Induced by New Therapeutic Vaccines - Eleanor Barnes, PhD, FRCP, F Med Sci
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Pharmacological Considerations When Choosing Optimal Treatment Regimen - Marta Boffito, MD, PhD, FRCP
Presented at:
GCC HIV Clinical Forum 2022
Slidesets
Establishing functional control of HBV and HDV infection with REP 2139-based combination therapy | Andrew Vaillant
Presented at:
International Workshop on HBV Cure 2018
Slidesets
RNA interference- Bill Symonds, PharmD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
RTI 2021 - Laura Waters - Clinical Review: New RT Inhibitors – Doravirine
Presented at:
Leveraging Reverse Transcriptase in HIV 2021
E-Posters
Assessment of HIV-1 DNA quantification methods in the Italian HIV DNA Network - Ilaria Vicenti
Presented at:
European Meeting on HIV & Hepatitis 2021
Slidesets
Hepatic proton density fat fraction correlates with histologic measures of steatosis and is responsive to change in those measures in a multi-center nonalcoholic steatohepatitis clinical trial- Michael Middleton
Presented at:
International Workshop on NASH Biomarkers 2017